VEGFA and hepatocellular carcinoma: The silencing of ACKR3 also leads to decreased matrix metalloproteinase-2 (MMP2) and vascular endothelial growth factor (VEGF) expression, inhibiting migration and invasion of tumor endothelial cells in hepatocellular carcinoma [87].